Biocon ramps up biosimilar push, eyes global semaglutide rollout as capex eases
As Shreehas Tambe readies to take charge of the unified Biocon Group following the integration of Biocon Biologics, the company is entering what he calls a “capacity‑rich, demand‑heavy” phase—one where margins improve as capital and R&D intensity taper off.
Torrent Group enters diagnostics segment with India’s largest reference lab in Navi Mumbai
The 100,000‑sq‑ft lab spans 15 diagnostic disciplines and more than 3,500 test modalities, handling everything from molecular diagnostics and genomics to digital pathology, microbiology and transplant‑related testing.
CDSCO to get 1,500‑member scientific cadre, will speed up drug approvals
The government has agreed ‘in principle’ to the move and a proposal would be send for approval by March, DGCI Rajeev Singh Raghuvanshi has said
Will “remove rot of cough‑syrup manufacturing” by next production season: Central drug controller
The regulator has already inspected around 1,150 facilities, or 90% of cough syrup making plants, physically visiting plants and taking enforcement action wherever serious lapses were found.
IPO Action: Investors to see 9 public issues worth Rs 4,400 crore next week, 4 firms lined up for listing
Upcoming IPOs | The participants will see total five IPOs opening for subscription on the first day of next week i.e. February 23 including Clean Max Enviro Energy Solutions, and Shree Ram Twistex from the mainboard segment
Yashhtej Industries Rs 89-crore IPO closes with 1.35 times subscription, listing scheduled on February 25
Yashhtej Industries IPO | The company is raising Rs 88.88 crore via initial public offering (IPO) of 80.79 lakh shares at a price of Rs 110 per share.
Clean Max Enviro Energy raises Rs 921 crore via anchor book ahead of Rs 3,100-crore IPO
Clean Max Enviro Energy Solutions IPO | | The company is raising Rs 1,200 crore by issuing fresh shares, while promoters and investors will be selling shares worth Rs 1,900 crore via offer-for-sale.
Everstone‑backed Integris Medtech gets SEBI nod for IPO
The Everstone Capital–backed company, India’s second‑largest home‑grown diversified medtech platform by FY25 operating revenue, plans to raise up to Rs 925 crore through a fresh issue of shares, alongside an offer for sale of 21.67 million shares from existing investors and founders.
Integris Medtech, Anjali Labtech, APPL Containers, Alpine Texworld IPOs get approval from SEBI
SEBI has issued observations on the draft papers of Integris Medtech on February 13, and Anjali Labtech on February 17, while the observations issued by the regulator on draft document of APPL Containers, and Alpine Texworld on February 20.
The Reading List: February 20, 2026
Our research and opinion teams have curated a selection of articles and social media gems from the world of economy, business and finance for your weekend read
OPINION | Beyond Traceability: Making battery aadhaar strategically transformative
Battery Aadhaar can improve mineral governance and promote circularity. But without strong upstream strategy, MSME support and integration of the informal sector, traceability alone cannot ensure real energy security
Miltenyi Biotec sees big India opportunity as it advances Made‑for‑India CAR‑T therapies
Miltenyi is preparing to bring its pipeline of cancer and autoimmune‑targeted therapies to India.
Omnitech Engineering sets price band at Rs 216-227 per share for its Rs 583-crore IPO
Omnitech Engineering IPO | The initial public offering is a mix of fresh issue of shares worth Rs 418 crore, and an offer-for-sale of Rs 165 crore worth shares.
Medikabazaar looks to raise $50 million to fund next phase of growth
Medikabazaar is currently in discussions to raise $50 million in fresh capital, with $25 million already committed by existing investors.
Gaudium IVF mobilises Rs 49.5 crore via anchor book, Rs 165-crore IPO to open on February 20
Gaudium IVF IPO | The company is raising Rs 165 crore via initial public offering which comprises of fresh issue of 1.13 crore equity shares worth Rs 90 crore, and an offer-for-sale of 94.93 lakh shares amounting to Rs 75 crore by promoter.
Upcoming IPO | Omnitech Engineering IPO to hit Dalal Street on February 25, offer size reduced by over 30%
Omnitech Engineering IPO | The public issue is a combination of fresh issuance of shares worth Rs 418 crore, and an offer-for-sale of Rs 165 crore worth shares by promoter Udaykumar Arunkumar Parekh.
Gaudium IVF IPO opens tomorrow: GMP signals decent listing; key things to know before you apply
Gaudium IVF IPO GMP: The allotments are likely to be finalised by February 25, and the shares are scheduled to be listed on stock exchanges on February 27.
ONGC, Oil India shares jump up to 7% as rising US-Iran tensions push oil prices higher; HPCL, BPCL fall up to 4%
Oil prices are rallying as investors remain concerned over the possibility of US action against Iran.
Bank Nifty falls 1%, breaches key support levels amid overall market downturn: Check key trading levels
The Nifty Bank index has slipped below the 61,000 mark, snapping a three-session gaining streak.
Small, midcap stocks plunge up to 5% amid overall market weakness: Check top losers
Given persistent global uncertainties and elevated market volatility, traders are advised to maintain discipline and be selective, focusing on fundamentally strong stocks during market corrections, an analyst said.
HDFC Securities Reli Discusses Impact of Tighter Bank Financing On Capital mkt Stocks
Dhiraj Relli, MD & CEO of HDFC Securities, shares his perspective on the RBI’s decision to tighten lending norms for brokers effective April 1 and what it means for capital market players. With stricter bank financing and changes around cash collateral usage, the move is expected to impact trading activity, especially in the derivatives segment.
Relli explains how higher funding costs and reduced leverage could make intra-day trading more expensive, potentially leading to a 15–20% decline in F&O volumes. Prop traders and highly leveraged participants may feel the pressure first, raising concerns over earnings visibility for brokerage firms and other capital market-linked stocks.
The discussion also delves into whether the earnings hit will be short-term or structural, and how investors should approach capital market names amid evolving regulatory norms.
Sensex, Nifty tumble nearly 1.5%: Trump's possible action against Iran leaving markets jittery, say analysts
In the short run, we can expect a range-bound market with high volatility, an analyst said.
Sensex falls 1,200 pts, Nifty down 1.4%: Will bear attack continue or can bulls make a comeback? Analysts suggest trading levels
Nifty 50 has broken a key support level of 25,650 which was suggested by analysts.
Upcoming IPOs: Clean Max, PNGS Reva Diamond among 3 mainboard IPOs opening next week, check latest GMP
IPO news: The maiden public issue of Gaudium IVF will spill over from this week, after opening tomorrow (February 20).
Infosys, TCS, Coforge other IT stocks rise up to 2% after Wall Street tech rally
IT stocks: Today's rise comes after a massive tech selloff after Anthropic’s launch of new AI tools, leading to worries about an AI-led disruption in the sector.
